Issue Date: February 12, 2018
Charles River will curate for AstraZeneca
Charles River Laboratories has signed an agreement granting it access to AstraZeneca’s high-throughput screening (HTS) and compound management infrastructure. The research services provider will place scientists at AstraZeneca’s Centre for Lead Discovery in Cambridge, England, where they will manage the drug firm’s compound collection and run HTS with access to liquid handling and automated storage systems.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society